Detalles de la búsqueda
1.
Enoxaparin for outpatients with COVID-19: 90-day results from the randomised, open-label, parallel-group, multinational, phase III OVID trial.
Thromb Res
; 221: 157-163, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36396519
2.
Enoxaparin for primary thromboprophylaxis in symptomatic outpatients with COVID-19 (OVID): a randomised, open-label, parallel-group, multicentre, phase 3 trial.
Lancet Haematol
; 9(8): e585-e593, 2022 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-35779558
3.
Disparities in emergency department access, resource allocation, and outcomes between migrants and the local population.
Swiss Med Wkly
; 151: w30070, 2021 10 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-34751537
4.
Mimics and chameleons of COVID-19: patient presentation and accuracy of triage during the first wave.
Swiss Med Wkly
; 151: w30103, 2021 12 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-34874013
5.
Association of Frailty with Adverse Outcomes in Patients with Suspected COVID-19 Infection.
J Clin Med
; 10(11)2021 Jun 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34199572
6.
Direct Comparison of Clinical Characteristics, Outcomes, and Risk Prediction in Patients with COVID-19 and Controls-A Prospective Cohort Study.
J Clin Med
; 10(12)2021 06 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-34204453
7.
Comment to: Non-specific clinical presentations are not prognostic and do not anticipate hospital length of stay or resource utilization.
Eur J Intern Med
; 91: 85-86, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34218970
Resultados
1 -
7
de 7
1
Próxima >
>>